首页> 美国卫生研究院文献>Molecular Medicine Reports >Next-generation sequencing identifies novel mutations in the FBN1 gene for two Chinese families with Marfan syndrome
【2h】

Next-generation sequencing identifies novel mutations in the FBN1 gene for two Chinese families with Marfan syndrome

机译:下一代测序鉴定了两个中国人患有马凡氏综合症的FBN1基因的新突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Marfan syndrome (MFS) is an autosomal dominant heterogeneous disorder of connective tissue characterized by the early development of thoracic aneurysms/dissections, together with defects of the ocular and skeletal systems. Loss-of-function mutations in fibrillin-1 (FBN1) encoded by the gene, FBN1 (MFS-1), and in the transforming growth factor β receptor 2 (TGFBR2) gene, TGFBR2 (MFS-2), are major causes of this disorder. In the present study, a rapid and cost-effective method for genetically diagnosing MFS was described and used to identify disease-causing mutations in two unrelated pedigrees with MFS in mainland China. Using targeted semiconductor sequencing, two pathogenic mutations in four MFS patients of the two pedigrees were identified, including a novel frameshift insertion, p.G2120fsX2160, and a reported nonsense mutation, p.Arg529X (rs 137854476), in the FBN1 gene. In addition, a rare, probably benign Chinese-specific polymorphism in the FBN1 gene was also revealed.
机译:马凡氏综合症(MFS)是结缔组织的常染色体显性异质性疾病,其特征是胸壁动脉瘤/解剖的早期发展以及眼和骨骼系统的缺陷。由该基因FBN1(MFS-1)编码的原纤维蛋白1(FBN1)和转化生长因子β受体2(TG​​FBR2)基因TGFBR2(MFS-2)编码的功能丧失突变是导致该功能丧失的主要原因。这种疾病。在本研究中,描述了一种快速且经济高效的遗传诊断MFS的方法,并用于鉴定中国大陆两个与MFS无关的家系的致病突变。使用靶向半导体测序,在两个谱系的四名MFS患者中鉴定出两个致病突变,包括FBN1基因中新的移码插入p.G2120fsX2160和报道的无意义突变p.Arg529X(rs 137854476)。此外,还发现了FBN1基因中罕见的,可能是良性的中国特异性多态性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号